Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. (MRTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MRTX · as of Jun 8, 2026
Key Statistics
Explore Mirati Therapeutics, Inc. Data
mrtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 31 · Buy rate: 45.2%
The MRTX analyst consensus is Hold, based on ratings from 31 Wall Street analysts over the past 3 months. The average 12-month price target is $102.10, representing +73.94% upside from the current price of $58.70.
Competitors & Peers
mrtx competitorsMRTX
ALPN
CBAY
ISEE
KDNY
MORStock Performance
Full HistoryAbout Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the clinical stage, committed to identifying and developing treatments that target the genetic and immunological factors drivi…
what is mirati therapeutics, inc. · mrtx stock overview · mirati therapeutics, inc. company profile · who is mirati therapeutics, inc. ceo · mrtx NASDAQ · mirati therapeutics, inc. headquarters · mirati therapeutics, inc. business segments
About Stock Overview & Key Data
Mirati Therapeutics, Inc. (MRTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 15, 2013. As of the latest trading session, MRTX stock price is $58.70, with a market capitalization of $4.1B. The stock has returned +29.44% over the past 12 months and -0.69% year-to-date.
According to 31 Wall Street analysts, the consensus rating for Mirati Therapeutics, Inc. stock is Hold, with an average 12-month price target of $102.10. In fiscal year 2022, Mirati Therapeutics, Inc. reported revenue of $12.4M and net income of -$740.9M. For detailed data — including Mirati Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mirati Therapeutics, Inc. (MRTX) stock price is $58.70. The stock is traded on NASDAQ under the ticker symbol MRTX. The 52-week range is $27.30 – $64.41.